Volume 12, Number 4, July-August 2005

New analysis of LIFE trial shows reduction of new-onset atrial fibrillation with losartan
Brian Crichton

A new analysis of the LIFE study has shown that losartan can reduce new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. General practitioner Brian Crichton summarises this new analysis and explains how losartan might achieve these effects.

Br J Cardiol 2005;12:268-269.

View full PDF article (open in new window)
Email this article